Azapropazone
Clinical data | |
---|---|
Trade names | Rheumox |
AHFS/Drugs.com | International Drug Names |
ATC code | M01AX04 (WHO) |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Biological half-life | 20 hours |
Identifiers | |
| |
CAS Number | 13539-59-8 |
PubChem (CID) | 26098 |
ChemSpider | 24310 |
UNII | K2VOT966ZI |
KEGG | D02966 |
ChEBI | CHEBI:38010 |
ChEMBL | CHEMBL1231131 |
Chemical and physical data | |
Formula | C16H20N4O2 |
Molar mass | 300.36 g/mol |
3D model (Jmol) | Interactive image |
Chirality | Racemic mixture |
| |
| |
(what is this?) (verify) |
Azapropazone is a non-steroidal anti-inflammatory drug. It is manufactured by Goldshield under the tradename Rheumox.[1]
It was available in the UK as a prescription-only drug, with restrictions due to certain contra-indications and side-effects.[2] Azopropazone has now been discontinued in the British National Formulary.
Azapropazone has a half-life of approximately 20 hours in humans and is not extensively metabolized.[3]
References
- ↑ http://home.intekom.com/pharm/cont_eth/rheumox.html
- ↑ http://www.patient.co.uk/showdoc/30002267/
- ↑ Jones CJ (1976). "The pharmacology and pharmacokinetics of azapropazone - a review". Curr Med Res Opin. 4 (1): 3–16. doi:10.1185/03007997609109361. PMID 770078.
This article is issued from Wikipedia - version of the 4/19/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.